The reiteration of an Overweight rating by a reputable analyst like Louise Chen could instill confidence in investors and positively influence Merck & Co's stock price in the short term. The maintained price target of $135 suggests a potential upside from the current trading price, assuming the market aligns with the analyst's valuation.